Chisalita, Simona I <br/><br/>
Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.  [electronic resource] 

 -  Acta diabetologica  Mar 2009 
 - 35-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-5233 
<br/><br/><label>Standard No.: </label>10.1007/s00592-008-0055-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Apolipoproteins--blood<br/>Blood Glucose--drug effects<br/>C-Peptide--blood<br/>Carbamates--therapeutic use<br/>Cholesterol--blood<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--analogs & derivatives<br/>Insulin Aspart<br/>Insulin-Like Growth Factor Binding Protein 1--blood<br/>Insulin-Like Growth Factor I--metabolism<br/>Lipids--blood<br/>Lipoproteins--blood<br/>Male<br/>Middle Aged<br/>Piperidines--therapeutic use<br/>Proinsulin--blood